DrugDashboards

Prochlorperazine Edisylate

Prochlorperazine Edisylate · PROCHLORPERAZINE EDISYLATE 5 mg/mL · Injection · Intramuscular; Intravenous · Cardinal Health 107, LLC

NDC 55154-4183-05 · 5 VIAL in 1 BAG / 2 mL in 1 VIAL · ANDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $90.46 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA204147
TE code
AP
Approval date
Oct 15, 2013
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Prochlorperazine Edisylate (Injection)

LabelerStrengthFirst seenLast seen
Gland Pharma LimitedPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 3, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Cosette Pharmaceuticals, Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Fosun Pharma Usa IncPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Prochlorperazine Edisylate — NDC 55154-4183-05," retrieved September 3, 2026, https://drugdashboards.com/drug/55154418305.

Free to cite with attribution — see how the data is put together.